A guide to the ingredients and potential benefits of over-the-counter cleansers and moisturizers for rosacea patients

Journal of Clinical and Aesthetic Dermatology

Volumn 4, Issue 8, 2011, Pages 31-49

  Levin, Jacquelyn ^a   Miller, Richard ^b  

^a Largo Medical Center   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; POLYHYDROXYALKANOATE SYNTHASE; POVIDONE IODINE;

HUMAN; PH; PRURITUS; REVIEW; ROSACEA; SKIN IRRITATION; SKIN TIGHTNESS; SKIN WATER LOSS; STRATUM CORNEUM;

EID: 80755143641     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (82)

1. Levin J, Del Rosso JQ, Momin S. How much do we really know about our favorite cosmeceuticals? J Clin Aesthet Dermatol. 2010;3(2):22-41.
2. Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11):771-778.
3. Crawford GH, Pelle MH, and James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;327-341. (Pubitemid 39178655)
4. Del Rosso JQ. The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on assessment of skin characteristic study. Cutis. 2009;84:72-76
5. Lonne-Rahm SB, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venerol. 1999;79:460-461.
6. Chen DM, Crosby DL. Periorbital edema as an initial presentation of rosacea. J Am Acad Dermatol. 1997;37: 346-348. (Pubitemid 27350010)
7. Harvey DT, Fenske NA, Glass LF. Rosaceous lymphedema: a rare variant of a common disorder. Cutis. 1998;61:321-324. (Pubitemid 128473125)
8. Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009;55:77-81.
9. Buechner SA. Rosacea: an update. Dermatology. 2005;210: 100-108. (Pubitemid 40463198)
10. McAleer M, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol. 2010;63:33-39.
11. Dirschka T, Tronnier H, Folster-Holst R. Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis. Br J Dermatol. 2004;150:1136-1141. (Pubitemid 38932283)
12. Lonne-Rahm SB, Fischer T, Berg M. Stinging and Rosacea. Acta Derm Venereol (Stockh). 1999;79:460-461.
13. Pelle MT, Crawford GH, James WD. Rosacea: II. therapy. J Am Acad Dermatol. 2004;51(4):499-512.
14. Subramanyan K. Role of mild cleansing in the management of patient skin. Dermatol Ther. 2004;17:26-34.
15. Ananthapadmanabhan KP, Moore DJ, Subramanyan K, Misra M, Meyer F. Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleanser. Dermatol Ther. 2004;17:16-25.
16. Draelos ZD. Skin care for the sensitive skin and rosacea patient: the biofilm and new cleansing technology. Cosmet Dermat. 2006;19(8):520-522. (Pubitemid 46100503)
17. Misra M, Ananthapadmanabhan KP, Hoyberg K, et al. Correlation between surfactant-induced ultrastructural changes in epidermis and transepidermal water loss. J Soc Cosmet Chem. 1997;48:219-234.
18. Misra M, Ananthapadmanabhan KP. Quantitative analysis of surfactant induced ultrastructural chenages in lipids. In: Lal M, Lillford PJ, Naik VM, Prakash V, eds. Supramolecular and Colloidal Structures in Biomaterials and Biosubstrates. Proceedings of the 5th Royal Society Unilever-Indo-UK Forum in Materials Science and Engineering, January 10-14, 1999. London: Imperial College Press; 2000:183-196.
19. Draelos ZD. Concepts in skin care maintenance. Cutis. 2005;76(6 Suppl):19-25. (Pubitemid 43094510)
20. Draelos ZD. Facial hygiene and comprehensive management of rosacea. Cutis. 2004;73:183-187. (Pubitemid 38453136)
21. Bikowski JB. The use of cleansers as therapeutic concomitants in various dermatologic disorders. Cutis. 2001;68(5):12-19.
22. Draelos ZD. Cosmetics in acne and rosacea. Semin Cutan Med Surg. 2001;20:209-214. (Pubitemid 32927784)
23. Kirsner RS, Froelich CW. Soaps and detergents: understanding their composition and effect. Ostomy Wound Management. 1998;44(3A):62S-70S.
24. Effendy I, Maibach HI. Detergent and skin irritation. Clin Dermatol. 1996;14:15-21. (Pubitemid 26096023)
25. Ertel K. Modern skin cleansers. Dermatol Clin. 2000;18: 561-575.
26. Dominquez JG, Balaguer F, Parra JL, Pelejero CM. The inhibitory effect of some amphoteric surfactants on the irritation potential of alkyl sulfayes. Int J Cosmet Soc. 1981;3(2):57-68. (Pubitemid 11076711)
27. Rhein LD, Robbins CR, Kernee K, Cantore R. Surfactant structure effects on swelling of isolated human stratum corneum. J Soc Cosmet Chem. 1986;37:125-139.
28. Wilhelm KP, Cua AB, Wolff HH, Maibach HI. Predicting surfactant induced stratum corneum hydration in vivo: prediction of the irritation potential of anionic surfactants. J Invest Dermatol. 1994;101:310-315. (Pubitemid 23269903)
29. Wilhelm KP, Wolff HH, Maibach, HI. Effects on surfactants on skin hydration. In: Elsner P, Berardesca E, Maibach HI, eds. Bioengineering of the Skin: Water and the Stratum Corneum. Boca Raton, FL: CRC Press; 1994:254-274.
30. Ananthapadmanabhan KP, Yu KK, Meyers CL, Aronson MP. Binding of surfactants to stratum corneum. J Soc Cosmet Chem. 1996;47:185-200.
31. Imokawa G, Sumra K, Katsumi M. Study on skin roughness caused by surfactants. II. Correlation between protein denaturation and skin roughness. J Am Oil Chem Soc. 1975;52:484-489.
32. Rhein LD. In vitro interactions: biochemical and biophysical effects of surfactants on skin. In: Rieger MM, Rhein LD, eds. Surfactants in Cosmetics. Surfactant Science Series. New York: Marcel Dekker; 1997:397-425.
33. Imokawa G. Surfactant mildness. In: Riegerc MM, Rhein LD, eds. Surfactants in Cosmetics. Surfactant Science Series. New York: Marcel Dekker; 1997:427-471.
34. Rawlings AW, Watkinson A, Rogers J, Mayo HJ, Scott IR. Abnormalities in stratum corneum structure, lipid composition, and desmosome degradation in soap-induced winter xerosis. J Soc Cosmet Chem. 1994;45:203-220.
35. de la Maza A, Coderch L, Lopez O, Baucells J, Parra JL. Permeability changes caused by surfactants in liposomes that model the stratum corneum lipid composition. J Am Oil Chem Soc. 1997;74(1):1-8. (Pubitemid 127551871)
36. Frebe CL, Simion FA, Rhein LD, Cagan RH, Kligman A. Stratum corneum lipid removal by surfactants: relation to in vivo irritation. Dermatologica. 1990;181:277-283.
37. Downing DT, Abraham W, Wegner KK, William KW, Marshal JL. Partition of sodium dodecyl sulfate into stratum corneum lipid liposomes. Arch Dermatol Res. 1993;285(3):151-157. (Pubitemid 23180344)
38. Mendelsohn R, Moore DJ. Infrared determination of conformational order and phase behavior in ceramides and stratum corneum models. Meth Enzymol. 2000;312:228-247.
39. Moore DJ. Stratum corneum lipids and barrier function: biophysical studies of molecular organization in sphingomyelin and ceramide [NS] bilayers. Recent Res Dev Lipids. 2002;6:55-63.
40. Levin J, Maibach HI. Human skin buffering capacity: overview. In: Zhai H, Wilhelm KP, Maibach HI, eds. Marzulli and Maibach's Dermatotoxicology, Seventh Edition. Boca Raton, FL: CRC Press, Taylor and Francis Group; 2008: 971-980.
41. Fluhr JW, Kao J, Jain M, et al. Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol. 2001;117:52-58.
42. Del Rosso JQ. The role of maintaining proper barrier function in the management of rosacea. Cosmet Dermatol. 2007;20(8): 485-490. (Pubitemid 47338972)
43. Bikowski JB. Rosacea: a tiered approach to therapy. Cutis. 2000;66(4):3-6.
44. Draelos ZD. The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea. Cutis. 2006;77(4):27-33. (Pubitemid 43723535)
45. Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Dermatol Ther. 2004;17:49-56.
46. Loden M. The clinical benefit of moisturizers 2005. J Euro Acad Dermatol Venereol. 2005;19:672-688.
47. Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants. Cutis. 2005;75:17-21. (Pubitemid 40521803)
48. Ghadially R, Halkiersorenson L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol. 1992;26:387-396.
49. Johnson AW. The moisturizer marketplace. In: Leyden J, Rawlings A, eds. Skin Moisturization. New York: Marcel Dekker, Inc.; 2002:1-30.
50. Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol Ther. 2004;17:43-48.
51. Rawlings AV, Scott IR, Harding CR, Bowser PA. Stratum corneum moisturization at the molecular level. J Invest Dermatol. 1994;103(5):731-740. (Pubitemid 24350145)
52. Menon GK, Norlen L. Stratum corneum ceramides and their role in skin barrier function. In: Leyden J, Rawlings A, eds. Skin Moisturization. New York: Marcel Dekker, Inc.; 2002:31-60.
53. Bouwstra JA, de Graaff A, Gooris GS, et al. Water distribution and related morphology in human stratum corneum at different hydration levels. J Invest Dermatol. 2003:120: 750-758. (Pubitemid 36529073)
54. Odom R, Dahl M, Dover J, et al. Standard management options for rosacea, part 1: overview and broad spectrum of care. Cutis. 2009;84:43-47.
55. Fan W, Kinnunen T, Niinimake A, et al. Skin reactions to glycols used in dermatological and cosmetic vehicles. Am J Contact Dermat. 1991;2:181-183.
56. Frosch PJ, Kligman AM. A method for appraising the stinging capacity of topically applied substances. J Soc Cosmet Chem. 1977;28:197-209. (Pubitemid 8138161)
57. Barany E, Lindberg M, Loden M. Unexpected skin barrier influence from nonionic emulsifiers. Int J Pharm. 2000;195:189-195. (Pubitemid 30089503)
58. Donbrow M, Azaz E, Pillersdorf A. Autoxidation of polysorbates. J Pharm Sci. 1978;67:1676-1681. (Pubitemid 9086684)
59. Goddard ED. Substantivity through cationic substitution. Cosmetics & Toiletries. 1987;102:71-80.
60. Draelos ZD, Ertel K, Berge C. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005;76:135-141. (Pubitemid 41290900)
61. Potts RO. Stratum corneum hydration: experimental techniques and interpretations of results. J Soc Cosmet Chem. 1986;37:9-33. (Pubitemid 16135207)
62. Draelos ZD. The effect of ceramide-containing skin care products on eczema resolution duration. Cutis. 2008;81:87-91.
63. Del Rosso JQ, Lehman PA, Raney SG. Impact of order of application of moisturizers on percutanous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model. Cutis. 2009;83:119- 124.
64. Del Rosso JQ. Understanding skin cleansers and moisturizers: the correlation of formulation with the art of clinical use. Cosmet Dermatol. 2003;16:19-31.
65. Mao-Qiang M, Brown BE, Wu-Pong S, et al. Exogenous nonphysiologic vs. physiologic lipids: divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol. 1995;131:809-816.
66. Thornfeldt C. Critical and optimal molar ratios of key lipids. In: Loden M, Maibach HI, ed. Dry Skin and Moisturizers: Chemistry and Function. Boca Raton, FL: CRC Press; 2000:337-347.
67. Man MQ, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated marine skin. Arch Dermatol. 1993;129:728-738. (Pubitemid 23172776)
68. Held E, Lund H, Agner T. Effect of different moisturizers on SLS-irritated human skin. Contact Dermatits. 2001;44:229-234. (Pubitemid 32234758)
69. Zettersten EM, Ghadially R, Feingold KR, et al. Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol. 1997;37: 403-408. (Pubitemid 27430637)
70. Loden M, Barany E. Skin-identical lipids versus petrolatum in the treatment of tape-stripped and detergent-perturbed human skin. Acta Derm Venereol. 2000;80:412-415. (Pubitemid 32156221)
71. De Paepae K, Derde M-P, Reseeuw D, et al. Incorporation of ceramide 3B in dermatocosmetic emulsions: effect of the transepidermal water loss of sodium lauryl sulphate-damaged skin. J Eur Acad Dermatol Venerol. 2000;14:272-279. (Pubitemid 32898919)
72. Bikowski J, Torok H, Torok H. Rosacea management: a three-pronged approach. Practical Dermatology. 2007;65-68.
73. Bikowski J. The use of cleansers as therapeutic in various dermatologic disorders. Cutis. 2001;68(5):12-19.
74. Draelos ZD. Clinical situations conductive to proactive barrier enhancement. Cutis. 2002;70(6):17-23.
75. Personal communication: James Q. Del Rosso, DO. November 13, 2010; (Priming the skin concept first presented by Dr. Del Rosso at Fall Clinical Dermatology; Las Vegas, Nevada; October 2010).
76. Hawkins SS, Subramanyan K, Liu D, et al. Cleansing, moisturizing, and sun-protection regimens for normal skin, self-percieved sensitive skin, and dermatologist-assessed sensitive skin. Dermatol Ther. 2004;17:63-68.
77. Draelos ZD, Green BA, Edison BL. An evaluation of a polyhydroxy skin care regimen in combination with azelaic acid 15% gel in rosacea patients. J Cosmet Dermatol. 2006;5:23-29.
78. Berardesca E, Distante F, Vignoli GP, Oresajo C, Green B. Alpha hydroxyacids modulate stratum corneum barrier function. Br J Dermatol. 1997;137:934-938. (Pubitemid 28011134)
79. Laquieze S, Czernielewski J, Baltas E. Beneficial use of Cetaphil Moisturizing Cream as a part of a daily skin care regimen for individuals with rosacea. J Dermatol Treat. 2007;18:158-162. (Pubitemid 46854831)
80. Elewski BE, Fleischer AB, Pariser DM. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea. Arch Dermatol. 2003;139:1444-1450. (Pubitemid 37433134)
81. Del Rosso JQ, Baum EW. Comprehensive medical management of rosacea: an interim study report and literature review. J Clin Aesthet Dermatol. 2008;1:20-25.
82. Torok HM. Rosacea skin care. Cutis. 2000;66(Suppl 4):14-16